8-K

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

FORM 8-K

CURRENT REPORT

Pursuant to Section 13 or 15(d) of

The Securities Exchange Act of 1934

Date of Report (Date of earliest event reported) May 26, 2006

The Cooper Companies, Inc.

(Exact name of registrant as specified in its charter)

DELAWARE	1-8597	94-2657368
(State or other jurisdiction of incorporation)	(Commission File Number)	(IRS Employer Identification No.)

6140 Stoneridge Mall Road, Suite 590, Pleasanton, California	94588
(Address of principal executive offices)	(Zip Code)

Registrant’s telephone number, including area code (925) 460-3600

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):

¨ Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

¨ Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

¨ Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

¨ Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

Table of Contents

ITEM 8.01.	Other Events	3
ITEM 9.01.	Financial Statements and Exhibits	3
SIGNATURE		4
EXHIBIT INDEX		5
EX-99.1 (Exhibits not specifically designated by another number and by investment companies)		6

ITEM 8.01.  Other Events.

On May 26, 2006, The Cooper Companies, Inc., issued a press release regarding organizational changes at its CooperVision unit. A copy of this release is attached and incorporated by reference.

Internet addresses in this release are for information purposes only and are not intended to be hyperlinks to other Cooper information.

ITEM 9.01.  Financial Statements and Exhibits.

(d) Exhibits.

Exhibit No.	Description
99.1	Press release dated May 26, 2006

3

SIGNATURE

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

THE COOPER COMPANIES, INC.
By	/s/    RODNEY E. FOLDEN
	Rodney E. Folden
	Corporate Controller (Principal Accounting Officer)

Dated: May 26, 2006

4

EXHIBIT INDEX

Exhibit No.	Description	Sequentially Numbered Page
99.1	Press release dated May 26, 2006	6

5

EX-99.1

Exhibit 99.1

Cooper Comments on Organizational Changes

LAKE FOREST, Calif., May 26, 2006 (PRIMEZONE) — The Cooper Companies, Inc. (NYSE:COO) said today in response to inquiries that its CooperVision unit has recently completed a realignment of its United States sales and marketing organization reducing the staff in these departments in the United States by 34 positions including 10 sales representatives.

The restructuring has been under study since early in the year as a part of the continuing integration of Ocular Sciences, Inc., which the company acquired in January of 2005, and balances field sales and telesales staffs to better meet customer requirements.

The Company also said that the launch of its Biofinity(r) silicone hydrogel contact lens in the United States remains on schedule. A limited introduction of the product is scheduled to begin mid-year in the United States.

Cooper plans to announce its fiscal second quarter results on June 6. A conference call discussing the quarterly results will be held at 5 p.m. Eastern Daylight Time.

The Cooper Companies, Inc. manufactures and markets specialty healthcare products through its CooperVision and CooperSurgical units. Corporate offices are in Lake Forest and Pleasanton, Calif. The World Wide Web address is www.coopercos.com. A toll free interactive telephone system at 1-800-334-1986 provides stock quotes, recent press releases and financial data.

CooperVision manufactures and markets contact lenses and ophthalmic surgery products. Headquartered in Lake Forest, Calif., it manufactures in Juana Diaz, Puerto Rico, Norfolk, Va., Rochester, N.Y., Adelaide, Australia, Hamble and Hampshire England, Ligny-en-Barrios, France, Madrid, Spain and Toronto. Its Web address is www.coopervision.com.

CooperSurgical manufactures and markets diagnostic products, surgical instruments and accessories to the women’s healthcare market. With headquarters and manufacturing facilities in Trumbull, Conn., it also manufactures in Pasadena, Calif., North Normandy, Ill., Fort Atkinson, Wis., Montreal and Berlin. Its Web address is www.coopersurgical.com.

CONTACT:   The Cooper Companies, Inc.

Norris Battin

888-822-2660

ir@coopercompanies.com

6